Tirzepatide Oral Tablets 500mcg
$100.00
Tirzepatide — dual GLP-1/GIP receptor agonist in oral tablet formulation. 500mcg per tablet, 50 tablets. Oral alternative for metabolic and weight management research without subcutaneous injection. ≥98% purity, HPLC-tested.
Research & Studies
Research Use Only
For in vitro laboratory research use only. Not for human consumption, medical use, or self-administration. Not evaluated by the FDA. Purchaser confirms they are a qualified researcher and assumes all responsibility for compliance with applicable federal, state, and local laws. This compound may be regulated as a controlled substance or prescription drug in certain jurisdictions.
In Vitro Research Protocol Reference
Research Concentration
2.5–15 mg
Frequency
Once weekly
Administration
Subcutaneous injection
Dual GLP-1/GIP agonist. Published research references gradual concentration escalation protocols.
Tirzepatide Oral Tablets 500mcg
$100.00
Frequently Bought Together
CJC-1295 + Ipamorelin 10mg
$45.00
Epithalon 10mg
$35.00
AOD9604 5mg
$35.00